Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01208324 · ClinicalTrials.gov registry record · NA

Estrogen and Serotonin on Changing Brain Chemistry

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT01208324 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01208324, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The aim of this study is to examine the effects of estrogen and serotonin on cognition, emotional processing, and brain activation. The investigators will study the effects of acute tryptophan (TRP) depletion on cognition and mood in healthy menopausal women before and after estrogen replacement treatment (ERT). Using functional magnetic resonance imaging (fMRI), the investigators will identify differences in brain activation during memory tasks with and without TRP depletion and before and after estrogen therapy in order to determine which brain regions and cognitive functions are affected by each manipulation.

Interventions

  • DRUG Placebo Patch
  • DRUG Placebo pills
  • DRUG Amino acids
  • DRUG estrogen patch

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2010-03-04
Est. Completion 2018-11
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01208324

The ClinicalTrials.gov registry entry for NCT01208324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo Patch is the first listed.

NCT01208324 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01208324 about?

NCT01208324 is a clinical study titled "Estrogen and Serotonin on Changing Brain Chemistry". The aim of this study is to examine the effects of estrogen and serotonin on cognition, emotional processing, and brain activation. The investigators will study the effects of acute tryptophan (TRP) depletion on cognition and mood in healthy menopausal women before and after estrogen replacement tre...

What is the current status of trial NCT01208324?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2010-03-04. Estimated completion is 2018-11.

What interventions are being tested in trial NCT01208324?

The interventions under investigation include: Placebo Patch (DRUG), Placebo pills (DRUG), Amino acids (DRUG), estrogen patch (DRUG).

Who is sponsoring clinical trial NCT01208324?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.